What Is a Good HRV? Understanding Your Heart Rate Variability Score

A heart rate variability score can look reassuringly precise, yet the number is rarely meaningful on its own. Is an HRV of 30 milliseconds low? Is 60 good? Should you be concerned when your score drops overnight?

So, what is a good HRV? In general, a good HRV is one that is appropriate for your age, physiology and measurement method, and remains stable or improves relative to your usual baseline. Higher values are often associated with stronger parasympathetic activity, physical fitness and recovery, although there is no single score that is ideal for everyone.

Your age, sleep, activity, stress, medication, illness and even the device you use can all influence the result. Understanding these factors is more useful than comparing one isolated number with a universal target.

What Does an HRV Score Measure?

Heart rate variability, or HRV, describes the subtle differences in time between consecutive heartbeats.

Your heart may appear to beat at a steady rhythm, but the interval between individual beats continually changes. One beat might follow the previous beat after 820 milliseconds, the next after 870 milliseconds and the next after 845 milliseconds.

These variations are influenced by the autonomic nervous system, which helps regulate functions such as heart rate, breathing, circulation, digestion, and recovery.

The autonomic nervous system has two main branches:

• the sympathetic nervous system, which helps mobilise the body during activity or stress;

• the parasympathetic nervous system, which supports rest, digestion and recovery.

The vagus nerve is a major parasympathetic pathway. Under consistent resting conditions, higher HRV is generally associated with greater vagal influence and a stronger capacity to adapt to changing physiological demands.

This does not mean that a high score proves you are healthy or that a low score diagnoses a health issue. HRV is best understood as one piece of physiological information rather than a standalone assessment.

What Is Considered a Good HRV?

There is no universally accepted good HRV number because values vary considerably between individuals.

Depending on age, fitness and measurement method, typical readings can range from below 20 milliseconds to well above 100 milliseconds. Oura Ring, for example, notes that HRV values among its users can range from under 20 to more than 200 milliseconds and recommends comparing current readings with personal historical trends rather than with other people.

As a broad guide for resting RMSSD:

• 40–60 ms is commonly observed in younger adults;

• 25–40 ms is frequently seen through middle age;

• values in the high teens or twenties become more common after the age of 60.

These are population reference points rather than clinical cut-offs. Within every age group, there is a wide spread of values, and a score outside the average range is not automatically unhealthy.

A good HRV score is therefore better described as a value that:

• is broadly appropriate for your age and measurement method

• remains reasonably stable across several weeks

• responds predictably to sleep, activity, stress and recovery

• is not accompanied by concerning symptoms

What Is a Good HRV for My Age?

HRV generally becomes lower with age.

In the Lifelines Cohort Study, researchers analysed short resting electrocardiograms from more than 84,000 participants. Median RMSSD declined steadily from adolescence until around the age of 60, after which it became more stable.

Median values for women and men were approximately:

These values are derived from resting RMSSD data and are intended to provide context rather than serve as diagnostic thresholds.

A score of 30 ms may therefore be below the population median for someone in their twenties, close to average during middle age and above the median for an older adult.

Age provides useful context, but your own baseline remains important. Someone who consistently records 28–32 ms may have a more stable pattern than someone whose HRV normally sits at 70 ms and suddenly falls to 35 ms.

Why Your Device Changes the Meaning of the Number

Before deciding whether you have a good HRV score, check exactly what your device measures.

RMSSD

RMSSD measures short-term differences between consecutive heartbeat intervals. It is particularly sensitive to parasympathetic influences and is commonly used in wearables for overnight or short-rest measurements.

SDNN

SDNN measures overall variability across the recording period. It is commonly used in clinical electrocardiography and may also appear in consumer health platforms.

Recording duration matters considerably. SDNN calculated from a five-minute recording cannot be interpreted in the same way as SDNN calculated from a 24-hour Holter monitor. Clinical research has shown that HRV reference values vary with the metric, age, sex, and recording length.

Measurement timing

HRV may be measured:

• throughout the night

• during a short morning reading

• during a breathing or meditation session

• intermittently during the day

• through a clinical ECG or 24-hour monitor

Posture, movement, breathing, meals and emotional stimulation can all influence a daytime reading. Two devices may therefore produce different scores without either device necessarily being wrong.

The most reliable comparisons are made using the same device, metric and measurement conditions.

What Is a Good HRV While Sleeping?

A good sleeping HRV is one that is reasonably stable relative to your normal overnight range and reflects adequate recovery over time.

Sleep measurements are often easier to compare because the body is relatively still and many daytime influences are reduced. Oura calculates overnight HRV using repeated five-minute RMSSD samples and reports the average across the night.

However, sleeping HRV still changes across different sleep stages and can be affected by:

• alcohol

• late or heavy meals

• disrupted or shortened sleep

• intense exercise

• psychological stress

• infection or emerging illness

• dehydration

• medication

• hormonal changes

• travel and altered routines

One lower night is rarely meaningful in isolation. A seven-day average or longer trend usually provides a clearer picture of whether your overnight HRV is stable, improving or consistently suppressed.

It is also important to compare like with like - an overnight RMSSD average should not be assessed against a daytime SDNN value or a reference range derived from a 24-hour clinical recording.

Is a Higher HRV Always Better?

Higher HRV is generally favourable when it represents a stable pattern under consistent resting conditions. It may reflect strong parasympathetic regulation, cardiovascular fitness and an ability to recover from physical or psychological demands.

However, the goal should not be to maximise HRV indefinitely.

An unusually high or erratic value can sometimes result from:

• poor sensor contact

• movement artefacts

• missed or incorrectly identified heartbeats

• an irregular cardiac rhythm

• a change in the device’s measurement method

A sudden increase is therefore not always evidence of better recovery, just as a temporary decrease does not necessarily indicate poor health.

The most useful pattern is usually one that is stable, responsive and consistent with how you feel.

What Can Lower HRV Temporarily?

HRV is sensitive to physiological strain, which is one reason it can be useful for tracking recovery.

Common causes of a temporary decrease include insufficient sleep, alcohol consumption, an unusually demanding workout, inadequate recovery between training sessions, emotional pressure, infection or inflammation, dehydration, under-eating or restrictive dieting, long-distance travel or certain medicines.

A lower reading may be the nervous system responding appropriately to increased demand. When the contributing factor resolves, HRV often returns towards the person’s usual range.

A sustained decrease becomes more meaningful when it occurs alongside fatigue, disrupted sleep, reduced exercise performance, a higher resting heart rate or difficulty recovering from everyday stress.

How to Find Your Personal Good HRV Range

Rather than searching for one perfect score, establish a reliable personal baseline.

Measure consistently

Use the same device at approximately the same time and under similar conditions. Avoid comparing readings from different platforms unless they use the same metric and protocol.

Track several weeks

Two to four weeks of regular measurements provide a more useful baseline than a few isolated readings.

Follow a moving average

A seven-day average reduces the effect of normal day-to-day variation and makes sustained changes easier to recognise.

Add context

Record factors that may explain changes, such as sleep duration, exercise, alcohol, illness, travel and unusual stress.

Consider how you feel

HRV is most informative when interpreted alongside energy, sleep quality, exercise tolerance and general recovery.

A stable score that aligns with feeling well may be more useful than a higher number accompanied by poor sleep or persistent symptoms.

How to Support a Good HRV

HRV is influenced by many of the same foundations that support cardiovascular and autonomic health.

Prioritise consistent sleep

Regular sleep and waking times can create a more predictable recovery rhythm. Reducing alcohol, heavy meals and stimulating activity close to bedtime may also support overnight HRV.

Balance activity with recovery

Regular aerobic activity, strength training and everyday movement can support autonomic and cardiovascular function. Intense exercise may temporarily lower HRV, so training needs to be balanced with sufficient rest.

Use comfortable slow breathing

Slow breathing can influence respiratory rhythm and cardiac vagal activity. One practical approach is to breathe gently at approximately five or six breaths per minute without straining or taking excessively deep breaths.

Address the underlying strain

Trying to increase HRV without considering why it has fallen can miss the more meaningful issue. Sleep loss, illness, alcohol, under-fuelling and sustained stress are often more important targets than the score itself.

Avoid over-monitoring

Wearable data should help you recognise patterns, rather than create pressure to produce a perfect number every morning. HRV naturally fluctuates, and occasional variation is expected.

From Understanding HRV to Supporting the Systems Behind It

Wearable devices can help identify changes in HRV and reveal patterns linked to sleep, stress, activity and recovery. Their role, however, is primarily observational: they measure changes in autonomic activity without directly engaging the neural pathways that contribute to the reading.

Non-invasive vagal neuromodulation offers a more active approach. Nurosym uses proprietary Auricular Vagal Neuromodulation Technology, or AVNT™, to deliver controlled electrical stimulation through the auricular branch of the vagus nerve at the ear.

Developed by Parasym over more than a decade, the technology is supported by 60+ completed studies and 100+ ongoing studies. Nurosym is designed to complement the everyday factors that shape HRV, including sleep, physical activity, nutrition and recovery, by providing a consistent method of supporting vagal and autonomic regulation.

Research on Nurosym, HRV and Autonomic Function

Clinical research using Parasym’s AVNT™ technology has examined HRV measures associated with cardiac vagal activity, alongside wider physiological outcomes relevant to autonomic regulation.

Reported findings include:

• 61% increase in vagus nerve activity, assessed through high-frequency power

• 18% increase in HRV, measured using RMSSD

• 45% improvement in an HRV measure associated with autonomic regulation, based on the HF/LF ratio used in the study

These outcomes are especially relevant when considering what constitutes a good HRV score because they reflect measurable changes in cardiac autonomic parameters rather than subjective experience alone.

30% Improvement in Sleep and 48% Reduction in Fatigue

HRV does not operate independently of the wider recovery state. Sleep quality and fatigue can both influence autonomic activity and affect how well the body responds to physical and psychological demands.

Studies using Parasym’s AVNT™ technology have reported:

• 30% improvement in sleep quality, measured using the Pittsburgh Sleep Quality Index

• 48% reduction in fatigue

These findings provide broader context for HRV by examining outcomes that may influence the body’s overall capacity for recovery.

78% Reduction in IL-6 and 28% Reduction in Oxidative Stress

The vagus nerve also contributes to communication between the nervous and immune systems. Research using AVNT™ has therefore explored inflammatory and oxidative processes that may interact with cardiovascular health, recovery and autonomic stability.

Reported findings include:

• 78% reduction in IL-6

• 23% reduction in TNF-α

• 28% reduction in oxidative stress

Cardiovascular and Circulatory Research

Further research has examined physiological outcomes related to cardiovascular and circulatory regulation.

Reported findings include:

• 45% reduction in postural heart-rate abnormalities

• 52% reduction in blood-pressure variability

• 10% reduction in diastolic blood pressure

• 50% improvement in blood-vessel flexibility

• 64% improvement in microcirculation markers

These outcomes were drawn from separate studies involving different populations, stimulation protocols and outcome measures. They illustrate the breadth of research into AVNT™ and autonomic function rather than representing typical or expected results for every user.

Safety and Tolerability

Nurosym’s safety and tolerability have also been evaluated in participants with complex cardiovascular conditions. A retrospective analysis covering more than 200 participants across several studies reported no device-related serious adverse events to date. Minor effects were uncommon and consisted of temporary tingling at the ear in a small number of participants.

Nurosym should be used in accordance with the product guidance. People with an implanted electronic device, a significant cardiovascular or neurological condition, or unexplained symptoms should seek advice from an appropriate healthcare professional before use. As safety has not been established across all populations, Nurosym is not recommended for children or during pregnancy.

When Should an HRV Change Be Discussed With a Healthcare Professional?

A low HRV score alone does not diagnose a medical condition.

Professional assessment is appropriate when a persistent or sudden change occurs alongside:

• fainting or recurrent dizziness

• palpitations or an irregular heartbeat

• chest discomfort

• shortness of breath

• unexplained exercise intolerance

• marked or persistent fatigue

• new neurological symptoms

Wearable measurements can provide supporting information, but they cannot replace an ECG or clinical assessment when symptoms suggest an underlying health concern.

What Is a Good HRV? The Key Takeaways

A good HRV is a value that makes sense for your age, physiology, device and measurement conditions, and remains reasonably stable relative to your personal baseline.

Higher HRV is often associated with stronger parasympathetic activity and recovery, although higher is not automatically better in every situation. The metric being used, the duration of the recording and whether the measurement was taken while awake or asleep all affect interpretation.

Your most useful benchmark is therefore your own trend, measured consistently and considered alongside sleep, exercise, stress, illness and how you feel.

For people who want to move beyond passive measurement, Nurosym offers a research-led form of auricular vagal neuromodulation designed to support autonomic regulation as part of a consistent daily routine. Backed by more than ten years of research and over five million user sessions worldwide, Nurosym offers a practical way to complement HRV monitoring with consistent, research-led support for autonomic regulation.

Disclaimer: Nurosym is a CE-marked medical device in Europe. The clinical research referenced in this article was conducted using Parasym’s neuromodulation technology under research conditions, some of which include populations outside of the device’s primary indication. Individual results may vary. All percentage figures cited reflect findings from specific study populations and should not be interpreted as a medical claim, and cannot guarantee outcomes for all users. Individuals should consult a qualified health professional regarding their personal health needs.

References:

1. Dalle Luche R, et al. First report of safety and tolerability of low-level tragus vagal neuromodulation in cardiovascular patients. J Am Coll Cardiol. 2024.

2. Geng Y, et al. Circadian stage-dependent and stimulation duration effects of transcutaneous auricular vagus nerve stimulation on heart rate variability. PLoS One. 2022.

3. Maestri R, et al. Impact of optimized transcutaneous auricular vagus nerve stimulation on cardiac autonomic profile in healthy subjects and heart failure patients. Physiol Meas. 2024.

4. Molaeizadeh G, et al. Effects of transcutaneous vagus nerve stimulation, neurofeedback, and their combination on cortisol, anxiety, and depression subtypes in non-clinical adults. 2025.

5. Stavrakis S, et al. TREAT AF — transcutaneous electrical vagus nerve stimulation to suppress atrial fibrillation: a randomised clinical trial. JACC Clin Electrophysiol. 2020.

6. Stavrakis S, et al. Noninvasive vagus nerve stimulation in postural tachycardia syndrome: a randomized clinical trial. JACC Clin Electrophysiol. 2023.

7. Dasari TW, et al. Effects of low-level tragus stimulation on endothelial function in heart failure with reduced ejection fraction. J Card Fail. 2021;27(5).

8. Dasari TW, et al. Noninvasive low-level tragus stimulation attenuates inflammation and oxidative stress in acute heart failure. Clin Auton Res. 2023.

9. Mbikyo E, et al. Low-level tragus stimulation attenuates blood pressure in young individuals with hypertension: results from a small-scale single-blind controlled randomized clinical trial. J Am Heart Assoc. 2024.

10. Zheng Y, et al. Transcutaneous vagus nerve stimulation improves Long COVID symptoms in a female cohort: a pilot study. Front Neurol. 2024.

11. Verbanck P, et al. Transcutaneous auricular vagus nerve stimulation (tVNS) can reverse the manifestations of the Long-COVID syndrome: a pilot study. Adv Neurol Neurosci Res. 2021.

12. Natelson B, Blate M, Soto T. Transcutaneous vagus nerve stimulation for long COVID and chronic fatigue symptoms. medRxiv. 2022.

13. Dolcini J, et al. Vagal nerve stimulation and fibromyalgia: an additional therapeutic option. Clin Exp Rheumatol. 2025.

14. Jackowska M, et al. Effects of transcutaneous vagus nerve stimulation on subthreshold affective symptoms and perceived stress: findings from a single-blinded randomized trial in community-dwelling adults. 2025.

15. Kamboj SK, et al. Electroceutical enhancement of self-compassion training using transcutaneous vagus nerve stimulation: results from a preregistered fully factorial randomized controlled trial. Psychol Med. 2025.

 

Terug naar blog